Hindustan Bio Sciences Ltd (BSE: 532041) is a Hyderabad, Telangana-based company in the Biological Products industry. With a market capitalisation of ₹7 Cr, it ranks #4,902 by market cap among the 6,197 Indian listed companies on FinBizNet, and #5 of 5 in Biological Products. At ₹6.87 (as of 16 Nov 2026), the share price is 30.7% below its 52-week high of ₹9.92 and 37.4% above its 52-week low of ₹5.00. The share price is down 0.4% over one year and up 1.9% over three months.
| Current Price | ₹6.87 |
|---|---|
| Market Cap | ₹7 Cr |
| BSE Code | 532041 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > Biological Products |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -9.12% |
| Return on Assets | -2.35% |
| 52-Week Range | ₹5.00 – ₹9.92 |
| 1-Year Price Change | -0.4% |
| 3-Month Price Change | +1.9% |
| Beta (1Y) | 0.42 |
| Headquarters | Hyderabad, Telangana |
| Website | www.hindustanbiosciences.in |
Promoters held 54.90% of Hindustan Bio Sciences Ltd's shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 95.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment manufactures and sells pharmaceutical products.
1. Trading of Drugs and Medicines-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Biocon Limited | ₹59,929 Cr | 131.2 | 1.15% | ₹4,389 Cr | -4.3% |
| Hester Biosciences Ltd | ₹1,985 Cr | 35.7 | 16.55% | ₹98 Cr | +46.0% |
| Zenotech Laboratories Ltd | ₹241 Cr | n/m | -1.12% | — | -22.5% |
| Transgene Biotek Ltd. | ₹19 Cr | n/m | -17.96% | ₹0 Cr | -22.1% |
| Hindustan Bio Sciences Ltd | ₹7 Cr | n/m | -9.12% | — | -0.4% |
Listed by market capitalisation. Ratios are shown for context only.
Hindustan Bio Sciences Ltd is trading at ₹6.87, with a market capitalisation of ₹7 Cr.
Hindustan Bio Sciences Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > Biological Products).
Hindustan Bio Sciences Ltd has a return on equity of -9.12%.
Hindustan Bio Sciences Ltd is listed on the BSE under the scrip code 532041.
Hindustan Bio Sciences Ltd's share price is down 0.4% over one year and up 1.9% over three months. Its 52-week range is ₹5.00 to ₹9.92.
Promoters held 54.90% of Hindustan Bio Sciences Ltd's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.